BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 3758370)

  • 21. Synthesis of N-(2-acetamido-2,3-dideoxy-D-glucopyranos-3-yl)glycyl-L-alanyl-D -isoglutamine analogues of muramyl dipeptide.
    Calvo-Mateo A; De Las Heras FG
    Carbohydr Res; 1986 Nov; 155():266-71. PubMed ID: 3791300
    [No Abstract]   [Full Text] [Related]  

  • 22. MDP and other muropeptides--direct and synergistic effects on the immune system.
    Traub S; von Aulock S; Hartung T; Hermann C
    J Endotoxin Res; 2006; 12(2):69-85. PubMed ID: 16690010
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biological properties of bacterial peptidoglycan.
    Johannsen L
    APMIS; 1993 May; 101(5):337-44. PubMed ID: 8329194
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biological activity of synthetic subunits of Streptococcus peptidoglycan. II. Relation of peptidoglycan subunits and analogues to fever effect and induction of tolerance.
    Rotta J; Zaoral M; Rýc M; Straka R; Jezek J
    Exp Cell Biol; 1983; 51(1):29-38. PubMed ID: 6832450
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Use of muramyl dipeptides in models of synthetic vaccines].
    Audibert F
    Boll Ist Sieroter Milan; 1985; 64(2):95-102. PubMed ID: 3896261
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and immunostimulating properties of lipophilic ester and ether muramyl peptide derivatives.
    Merhi G; Coleman AW; Devissaguet JP; Barratt GM
    J Med Chem; 1996 Oct; 39(22):4483-8. PubMed ID: 8893843
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of pentadecapeptide mimicking muramyl peptide.
    Laman AG; Shepelyakovskaya AO; Berezin IA; Boziev KM; Rodionov IL; Chulina IA; Malakhova GV; Brovko FA; Murashev AN; Korpela TK; Nesmeyanov VA
    Vaccine; 2007 Apr; 25(15):2900-6. PubMed ID: 17005302
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Synthesis and biological activity of aryl S-beta-glycosides of 1-thio-N-acetylmuramyl-L-alanyl-D-isoglutamine].
    Zemliakov AE; Tsikalova VN; Azizova LR; Chirva VIa; Mulik EL; Shkalev MV; Kaliuzhin OV; Kiselevskiĭ MV
    Bioorg Khim; 2008; 34(2):245-51. PubMed ID: 18522281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Muraceins--muramyl peptides produced by Nocardia orientalis as angiotensin-converting enzyme inhibitors. II. Isolation and structure determination.
    Singh PD; Johnson JH
    J Antibiot (Tokyo); 1984 Apr; 37(4):336-43. PubMed ID: 6327591
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of muramyl peptides on mitochondrial respiration.
    El-Jamal N; Bahr GM; Echtay KS
    Clin Exp Immunol; 2009 Jan; 155(1):72-8. PubMed ID: 19076831
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Muramyl peptides, serotonergic system, and sleep.
    Masek K; Kadlecová O
    Ann N Y Acad Sci; 1987; 496():517-21. PubMed ID: 2955728
    [No Abstract]   [Full Text] [Related]  

  • 32. A special grant for special patients from the American Cancer Society.
    Oncology (Williston Park); 1990 Mar; 4(3):99. PubMed ID: 2144451
    [No Abstract]   [Full Text] [Related]  

  • 33. [The defense mechanism and its weakening: modification of the defense mechanism by microbes--increase of sensitivity to bacterial endotoxins by bacterial components].
    Takada H; Kotani S
    Nihon Rinsho; 1986 Sep; 44(9):1972-80. PubMed ID: 3540366
    [No Abstract]   [Full Text] [Related]  

  • 34. [Recent advances in research on sleep-promoting substances].
    Jin GY
    Sheng Li Ke Xue Jin Zhan; 1987 Apr; 18(2):155-9. PubMed ID: 3310215
    [No Abstract]   [Full Text] [Related]  

  • 35. Autochthonous intestinal bacteria and coprophagy: a possible contribution to the ontogeny and rhythmicity of slow wave sleep in mammals.
    Brown R; Price RJ; King MG; Husband AJ
    Med Hypotheses; 1988 Jul; 26(3):171-5. PubMed ID: 3405123
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Key issues in the delivery of pharmacological agents using lipoproteins: design of a synthetic apoprotein-lipid carrier.
    Shaw JM; Shaw KV
    Targeted Diagn Ther; 1991; 5():351-83. PubMed ID: 1665722
    [No Abstract]   [Full Text] [Related]  

  • 37. Function and evolutionary changes in proteins: introductory remarks.
    Margoliash E
    Fed Proc; 1976 Aug; 35(10):2102-3. PubMed ID: 947790
    [No Abstract]   [Full Text] [Related]  

  • 38. Synthetic muramyl peptides.
    Lederer E
    Science; 1982 Oct; 218(4570):330. PubMed ID: 17739334
    [No Abstract]   [Full Text] [Related]  

  • 39. Current status and future directions of the analysis of verbal behavior: Introductory remarks.
    Schlinger HD
    Anal Verbal Behav; 1998; 15():93-6. PubMed ID: 22477130
    [No Abstract]   [Full Text] [Related]  

  • 40. Introductory remarks: Influence of nutritional status on growth-perspectives from field and clinic.
    Cronk CE
    Am J Hum Biol; 1989; 1(6):653-655. PubMed ID: 28597516
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.